[Bacteriological evaluation of clindamycin-2-phosphate (author's transl)]

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Clindamycin is a potent antibiotic effective against gram-positive and gram-negative cocci.
• Clindamycin-2-phosphate is a novel injectable formulation of clindamycin.

Purpose of the Study:

• To compare the in vitro and in vivo antibacterial activity of clindamycin-2-phosphate with clindamycin.
• To evaluate the influence of pH and inoculum size on the efficacy of both compounds.

Main Methods:

• Bacteriological evaluation of clindamycin-2-phosphate and clindamycin.
• In vitro susceptibility testing against various bacteria.
• In vivo therapeutic efficacy studies in mice with experimental infections.
• Assessment of pH and inoculum size effects on antibacterial activity.

Main Results:

• Clindamycin-2-phosphate exhibits weak intrinsic antibacterial activity.
• In vivo, clindamycin-2-phosphate is metabolized to clindamycin, restoring potent activity.
• Both compounds show increased antibacterial activity in alkaline conditions.
• Antibacterial activity is largely independent of inoculum size.
• Clindamycin-2-phosphate demonstrated comparable therapeutic effects to clindamycin in vivo despite lower in vitro activity.

Conclusions:

• Clindamycin-2-phosphate serves as an effective prodrug, delivering active clindamycin in vivo.
• The efficacy of clindamycin and its phosphate ester is pH-dependent, favoring alkaline environments.
• This injectable formulation offers a viable therapeutic option, particularly in conditions where clindamycin is indicated.